{"DataElement":{"publicId":"2957536","version":"1","preferredName":"Secondary Malignant Neoplasm Occurrence Date","preferredDefinition":"The month, day, and year the secondary malignancy occurred.","longName":"2957534v1.0:2532012v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2957534","version":"1","preferredName":"Secondary Malignant Neoplasm Occurrence","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._An instance of something happening, such as an event or incident.","longName":"2957532v1.0:2234856v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2957532","version":"1","preferredName":"Secondary Malignant Neoplasm","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25667:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77194757-47AF-A073-E040-BB89AD4326BE","latestVersionIndicator":"Yes","beginDate":"2009-10-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-29","modifiedBy":"ONEDATA","dateModified":"2009-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"77194757-47BD-A073-E040-BB89AD4326BE","latestVersionIndicator":"Yes","beginDate":"2009-10-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2532012","version":"2","preferredName":"Date","preferredDefinition":"The particular day, month and year an event has happened or will happen.","longName":"DATE","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"format":"YYYY-MM-DD","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A1B282-BBA9-1DAB-E040-BB89AD4319DD","latestVersionIndicator":"Yes","beginDate":"2009-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-28","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"Created new version associated to different CD and Display Format as part of NMDP Date VD clean up 4/2009. mcooper Corrected def from KM change. AK 3/25/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964872","version":"1","longName":"2000r1: Recipient Baseline Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cur_hsct_sec_malig_dte","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedObservation:dateRange ","type":"HCT_BRIDG","context":"NHLBI"},{"name":"PreTed_hct_2ndary_malig_date","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_hctc_2ndary_malig_date","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Date of secondary malignancy:","type":"Preferred Question Text","description":"Date of secondary malignancy:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2957536","type":"BRIDG Mapping Path","description":"PerformedObservation.dateRange WHERE PerformedObservation > PerformedDiagnosis.value [new] \"malignancy including PTLD and EBV\" AND PerformedObservation.dateRange IS GREATER THAN PerformedSubstanceAdministration.dateRange AND PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Perform Overall Hematopoetic Stem Cell Transplantation\" AND PerformedSubstanceAdministration > PerformedDiagnosis.value [first] = \"malignancy including PTLD and EBV\"","url":null,"context":"NHLBI"},{"name":"Date of secondary malignancy:","type":"Application Standard Question Text","description":"Date of secondary malignancy:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"77194757-47D6-A073-E040-BB89AD4326BE","latestVersionIndicator":"Yes","beginDate":"2009-10-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-29","modifiedBy":"KUMMEROA","dateModified":"2019-09-04","changeDescription":". Added alt name/ASQT for 2400. AK 10/7/13 Added human readable def. System generated def displayed as alt def. No version needed. AK 11/3/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}